S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|MELA Sciences, a Leader in the Fight Against Melanoma, to Release Second Quarter 2013 Financial Results and Host Conference Call on Wednesday, August 7, 2013 ()|
|MELA Sciences, a Leader in the Fight Against Melanoma, Appoints Dr. Darrell Rigel as Chief Medical Advisor to Its Board of Directors (2013/10/1)|
|MELA Sciences, a Leader in the Fight Against Melanoma, Appoints Tony Dimun to Its Board of Directors (2013/9/30)|
|MELA Sciences, a Leader in Melanoma Diagnostics, Appoints Rose Crane as President and Chief Executive Officer and a Director, Effective as of Monday, November 11th (2013/11/6)|
|MELA Sciences, a Leader in the Fight Against Melanoma, Announces Second Quarter 2013 Financial Results; Announces Restructuring ()|
|MELA Sciences, a Leader in the Fight Against Melanoma, to Release Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, November 6, 2013 (2013/10/14)|
|MELA Sciences, a Leader in Melanoma Diagnostics, Reports Third Quarter 2013 Results and Launch of New Strategic Plan (2013/11/6)|
|MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the American Society of Dermatologic Surgery Annual Meeting (2013/10/2)|
|MELA Sciences, Inc. to Participate in the Fall Clinical Dermatology Conference (2013/10/16)|
|MELA Sciences, Inc. Announces $6.0 Million Registered Offering (2013/10/30)|
Click above to view more mutual fund data and stats for mela - Mela Sciences, Inc..